RecruitingNot applicableNCT05984511

TACE Plus Atezolizumab/Bevacizumab and I-125 Seeds Brachytherapy for HCC With Branch PVTT

Studying Leukoencephalopathy with calcifications and cysts

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Third Affiliated Hospital, Sun Yat-Sen University
Principal Investigator
Mingsheng Huang, M.D. & Ph.D.
Department of Interventional Radiology, The Third Affiliated Hospital of Sun Yat-sen University
Intervention
I-125 Seeds Brachytherapy in PVTT(procedure)
Enrollment
234 target
Eligibility
18-75 years · All sexes
Timeline
20232029

Study locations (1)

Collaborators

Sun Yat-Sen University Cancer Center · Fifth Affiliated Hospital, Sun Yat-Sen University · Second Affiliated Hospital of Guangzhou Medical University · Maoming People's Hospital · Shandong Province Third hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05984511 on ClinicalTrials.gov

Other trials for Leukoencephalopathy with calcifications and cysts

Additional recruiting or active studies for the same condition.

See all trials for Leukoencephalopathy with calcifications and cysts

← Back to all trials